Olysio(Simeprevir 150mg)

$4,500.00$30,000.00

OLYSIO™ (simeprevir) is an NS3/4A protease inhibitor jointly developed by Janssen R&D Ireland and Medivir AB and indicated in the U.S. for the treatment chronic hepatitis C infection in combination with pegylated interferon and ribavirin in HCV genotype 1 infected subjects with compensated liver disease, including cirrhosis.

 

FOR THIS DRUG YOU CAN EITHER PAY IN FULL OR CREATE AND INSTALL-MENTAL PAYMENT SCHEDULE DEPENDING ON THE QUANTITY YOU WILL BE NEEDING AND THE NUMBER OF WEEKS YOU INTEND TO UNDER GO THE TREATMENT 

Clear
Browse Wishlist
SKU: N/A Category:
error: Content is protected !!
WhatsApp chat